DOMOSEDAN; DORMOSEDAN

Zoetis Inc

Revision date : 2013-12-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

200-338-0/57-55-6

Name of the chemical

1,2-propanediol

Concentration

*

EC/CAS

223-339-8/3844-45-9

Name of the chemical

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)

Concentration

*

General Information

Version

2.0

Revision date

2013-12-04

Product name

DOMOSEDAN; DORMOSEDAN

Chemical name

Mixture

1.2.1 Relevant identified uses

Veterinary product used as analgesic, sedative

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

Company Information

company name

Zoetis Inc

e-mail address of the competent person responsible for the Safety Data Sheet

VMIPSrecords@zoetis.com

GHS Information

Signal word

Not Classified

Hazard Codes

Hazard statements (CLP)

H301, H317

Hazard statements

Code

Statements

H301

Toxic if swallowed

Section 2

SECTION 2: Hazards identification

Appearance Blue gel Classification of the Substance or Mixture GHS - Classification Not classified as hazardous EU Classification EU Indication of danger Not classified

Signal word

Not Classified

Hazard statements

Non-hazardous in accordance with international standards for workplace safety.

Other hazards

Short Term May be toxic if swallowed. May be absorbed through mucous membranes and cause systemic effects. May cause eye irritation. May cause skin irritation. May cause allergic skin reaction . (based on components) . Known Clinical Effects This material is an alpha-2 adrenergic receptor agonist intended for animal use only. Symptoms reported after accidental human exposure have included drowsiness, decrease in blood pressure (hypotension), increase in blood pressure (hypertension), decreased heart rate (bradycardia), tingling sensation, numbness, pain, headache, sleepiness (somnolence), dilated pupils, and vomiting. Australian Hazard Classification (NOHSC) Non-Hazardous Substance. Non-Dangerous Goods. Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Not classified as hazardous EU Classification: EU Indication of danger: Not classified Label Elements

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.